Indo Us Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Biotech Limited has informed the stock exchanges that its trading window for dealing in shares will remain closed for all designated persons from October 1, 2025 until 48 hours after the announcement of unaudited financial results for the quarter and half year ending September 30, 2025. This closure is in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's internal code of conduct. The date of the board meeting to approve these Q2/H1 FY26 results has not yet been disclosed and will be communicated later.
This is a routine regulatory compliance filing and does not have a direct impact on shareholders or stock price. However, the upcoming board meeting and quarterly results announcement may be a near-term catalyst to watch for.